210 related articles for article (PubMed ID: 31149052)
21. Therapeutic efficacy and safety of TRAIL-producing human adipose tissue-derived mesenchymal stem cells against experimental brainstem glioma.
Choi SA; Hwang SK; Wang KC; Cho BK; Phi JH; Lee JY; Jung HW; Lee DH; Kim SK
Neuro Oncol; 2011 Jan; 13(1):61-9. PubMed ID: 21062796
[TBL] [Abstract][Full Text] [Related]
22. IFN-γ-primed human bone marrow mesenchymal stem cells induce tumor cell apoptosis in vitro via tumor necrosis factor-related apoptosis-inducing ligand.
Du J; Zhou L; Chen X; Yan S; Ke M; Lu X; Wang Z; Yu W; Xiang AP
Int J Biochem Cell Biol; 2012 Aug; 44(8):1305-14. PubMed ID: 22554587
[TBL] [Abstract][Full Text] [Related]
23. Histone deacetylase inhibitor panobinostat potentiates the anti-cancer effects of mesenchymal stem cell-based sTRAIL gene therapy against malignant glioma.
Choi SA; Lee C; Kwak PA; Park CK; Wang KC; Phi JH; Lee JY; Chong S; Kim SK
Cancer Lett; 2019 Feb; 442():161-169. PubMed ID: 30367915
[TBL] [Abstract][Full Text] [Related]
24. In vitro and in vivo discrepancy in inducing apoptosis by mesenchymal stromal cells delivering membrane-bound tumor necrosis factor-related apoptosis inducing ligand in osteosarcoma pre-clinical models.
Guiho R; Biteau K; Grisendi G; Chatelais M; Brion R; Taurelle J; Renault S; Heymann D; Dominici M; Redini F
Cytotherapy; 2018 Aug; 20(8):1037-1045. PubMed ID: 30093324
[TBL] [Abstract][Full Text] [Related]
25. DNA-binding Cell-penetrating Peptide-based TRAIL Over-expression in Adipose Tissue-derived Mesenchymal Stem Cells Inhibits Glioma U251MG Growth.
Shin J; Baik SK; Yoon Y; Hwang S; Sohn JH; Jo M; Kim WS; Rhee KJ; Whang K; Eom YW
Anticancer Res; 2021 Jun; 41(6):2859-2866. PubMed ID: 34083276
[TBL] [Abstract][Full Text] [Related]
26. Combination treatment with VPA and MSCs‑TRAIL could increase anti‑tumor effects against intracranial glioma.
Park SA; Han HR; Ahn S; Ryu CH; Jeun SS
Oncol Rep; 2021 Mar; 45(3):869-878. PubMed ID: 33469674
[TBL] [Abstract][Full Text] [Related]
27. Platelet-derived growth factor BB mediates the tropism of human mesenchymal stem cells for malignant gliomas.
Hata N; Shinojima N; Gumin J; Yong R; Marini F; Andreeff M; Lang FF
Neurosurgery; 2010 Jan; 66(1):144-56; discussion 156-7. PubMed ID: 20023545
[TBL] [Abstract][Full Text] [Related]
28. Effective combination therapy for malignant glioma with TRAIL-secreting mesenchymal stem cells and lipoxygenase inhibitor MK886.
Kim SM; Woo JS; Jeong CH; Ryu CH; Lim JY; Jeun SS
Cancer Res; 2012 Sep; 72(18):4807-17. PubMed ID: 22962275
[TBL] [Abstract][Full Text] [Related]
29. Exploiting tumor-intrinsic signals to induce mesenchymal stem cell-mediated suicide gene therapy to fight malignant glioma.
Li M; Sun S; Dangelmajer S; Zhang Q; Wang J; Hu F; Dong F; Kahlert UD; Zhu M; Lei T
Stem Cell Res Ther; 2019 Mar; 10(1):88. PubMed ID: 30867058
[TBL] [Abstract][Full Text] [Related]
30. Iron Oxide Nanoparticles Promote Cx43-Overexpression of Mesenchymal Stem Cells for Efficient Suicide Gene Therapy during Glioma Treatment.
Li A; Zhang T; Huang T; Lin R; Mu J; Su Y; Sun H; Jiang X; Wu H; Xu D; Cao H; Sun X; Ling D; Gao J
Theranostics; 2021; 11(17):8254-8269. PubMed ID: 34373740
[No Abstract] [Full Text] [Related]
31. Site-Specific Integration of TRAIL in iPSC-Derived Mesenchymal Stem Cells for Targeted Cancer Therapy.
Wang Z; Chen H; Wang P; Zhou M; Li G; Hu Z; Hu Q; Zhao J; Liu X; Wu L; Liang D
Stem Cells Transl Med; 2022 Mar; 11(3):297-309. PubMed ID: 35267023
[TBL] [Abstract][Full Text] [Related]
32. Exosomes derived from TRAIL-engineered mesenchymal stem cells with effective anti-tumor activity in a mouse melanoma model.
Shamili FH; Bayegi HR; Salmasi Z; Sadri K; Mahmoudi M; Kalantari M; Ramezani M; Abnous K
Int J Pharm; 2018 Oct; 549(1-2):218-229. PubMed ID: 30075248
[TBL] [Abstract][Full Text] [Related]
33. In vivo gene delivery by embryonic-stem-cell-derived astrocytes for malignant gliomas.
Uzzaman M; Keller G; Germano IM
Neuro Oncol; 2009 Apr; 11(2):102-8. PubMed ID: 18676359
[TBL] [Abstract][Full Text] [Related]
34. Probe-Based Confocal Laser Endomicroscopy for Imaging TRAIL-Expressing Mesenchymal Stem Cells to Monitor Colon Xenograft Tumors In Vivo.
Zhang Z; Li M; Chen F; Li L; Liu J; Li Z; Ji R; Zuo X; Li Y
PLoS One; 2016; 11(9):e0162700. PubMed ID: 27617958
[TBL] [Abstract][Full Text] [Related]
35. Polylysine-modified polyethylenimine polymer can generate genetically engineered mesenchymal stem cells for combinational suicidal gene therapy in glioblastoma.
Malik YS; Sheikh MA; Xing Z; Guo Z; Zhu X; Tian H; Chen X
Acta Biomater; 2018 Oct; 80():144-153. PubMed ID: 30223091
[TBL] [Abstract][Full Text] [Related]
36. Claudin-7 suppresses the cytotoxicity of TRAIL-expressing mesenchymal stem cells in H460 human non-small cell lung cancer cells.
Xia P; Wang W; Bai Y
Apoptosis; 2014 Mar; 19(3):491-505. PubMed ID: 24242915
[TBL] [Abstract][Full Text] [Related]
37. Stem cell-based gene therapy activated using magnetic hyperthermia to enhance the treatment of cancer.
Yin PT; Shah S; Pasquale NJ; Garbuzenko OB; Minko T; Lee KB
Biomaterials; 2016 Mar; 81():46-57. PubMed ID: 26720500
[TBL] [Abstract][Full Text] [Related]
38. The use of biodegradable PLGA nanoparticles to mediate SOX9 gene delivery in human mesenchymal stem cells (hMSCs) and induce chondrogenesis.
Kim JH; Park JS; Yang HN; Woo DG; Jeon SY; Do HJ; Lim HY; Kim JM; Park KH
Biomaterials; 2011 Jan; 32(1):268-78. PubMed ID: 20875683
[TBL] [Abstract][Full Text] [Related]
39. Activated human mesenchymal stem/stromal cells suppress metastatic features of MDA-MB-231 cells by secreting IFN-β.
Yoon N; Park MS; Shigemoto T; Peltier G; Lee RH
Cell Death Dis; 2016 Apr; 7(4):e2191. PubMed ID: 27077807
[TBL] [Abstract][Full Text] [Related]
40. Magnetic iron oxide nanoparticles mediated gene therapy for breast cancer--an in vitro study.
Wei W; Xu C; Wu H
J Huazhong Univ Sci Technolog Med Sci; 2006; 26(6):728-30. PubMed ID: 17357502
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
